| Metric | Value ($ M) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 5.6K | 0.1% | 6.5% |
| Total Income | 5.6K | 0.1% | 6.5% |
| Expenditure | 3.9K | 6.0% | 11.8% |
| PBT | — | ||
| Net Profit | 1.0K | 21.1% | 192.4% |
| OPM | 31.08% | 4.41pp | 14.27pp |
| NPM | 17.76% | 3.08pp | 11.29pp |
| EPS | 12.48 | 26.2% | 220.8% |
Tenet Healthcare Reports Strong Q3 2026 Results; Raises 2026 Financial Outlook
29 Oct 2026 · 29 Oct, 4:21 pm
Summary
Tenet Healthcare Corporation reported strong third quarter 2026 results, with net income available to common shareholders reaching $1.000 billion, or $12.41 per diluted share, up from $342 million in the prior year. Consolidated Adjusted EBITDA increased by 23.3% to $1.355 billion, and the company raised its full-year 2026 Adjusted EBITDA outlook to a range of $5.05 billion to $5.20 billion. Management attributed the outperformance to sustained strength in same-store revenue growth and effective expense management.
Key Highlights
- 1
Net income available to common shareholders in the third quarter of 2026 was $1.000 billion, or $12.41 per diluted share, a significant increase from $342 million, or $3.86 per diluted share, in the third quarter of 2025.
- 2
Adjusted diluted earnings per share increased by 79.5% to $6.64 in the third quarter of 2026 compared to $3.70 in the third quarter of 2025.
- 3
Consolidated Adjusted EBITDA for the third quarter of 2026 rose by 23.3% over the third quarter of 2025 to $1.355 billion, with an Adjusted EBITDA margin of 24.1%.
- 4
The Ambulatory Care segment's Adjusted EBITDA reached $537 million in the third quarter of 2026, an increase of 9.1% over the third quarter of 2025.
- 5
The FY 2026 Adjusted EBITDA outlook was raised to a range of $5.05 billion to $5.20 billion, an increase of $195 million at the midpoint.
- 6
Net operating revenues for the third quarter of 2026 were $5.631 billion, an increase of 6.5% compared to $5.289 billion in the third quarter of 2025.
Management Comments
Saum Sutaria
M.D.
Our outperformance in the third quarter of 2026 was driven by sustained strength in same-store revenue growth and effective expense management. Our focus on patient-centered care, support for physician partners, technology-enabled growth and operating initiatives continue to deliver strong margins and free cash flow.
Informational and educational content only. Not investment advice.